{"id":4665,"date":"2019-03-22T10:35:13","date_gmt":"2019-03-22T09:35:13","guid":{"rendered":"https:\/\/www.endoscopy-campus.com\/?post_type=bildergalerie&p=4665"},"modified":"2019-10-05T09:47:40","modified_gmt":"2019-10-05T07:47:40","slug":"stomach-light-blue-crest-sign-for-intestinal-metaplasia","status":"publish","type":"bildergalerie","link":"https:\/\/www.endoscopy-campus.com\/en\/bildergalerie\/stomach-light-blue-crest-sign-for-intestinal-metaplasia\/","title":{"rendered":"Stomach: Light Blue Crest Sign for Intestinal Metaplasia"},"content":{"rendered":"

Gastric Intestinal Metaplasiais<\/strong> a risk factor of intestinal-type gastric cancer, but WLI was not adequate to detect IM of stomach [1]. NBI system with and without magnification can excellently diagnose GIM with good histological agreement. Uedo et al. used a light blue crest (LBC) on epithelial surface by ME-NBI as a maker to diagnose IM with the sensitivity and specificity of 89% and 93%, respectively [2]. The LBC is a fine, blue-white line on the crests of the epithelial surface, and it can only be detected under wavelengths of 400\u2013430 nm.<\/p>

  1. M. M. Walker, \u201cIs intestinal metaplasia of the stomach reversible?\u201d Gut, vol. 52, no. 1, pp. 1\u20134, 2003. <\/em><\/li>
  2. N. Uedo, R. Ishihara, H. Iishi et al., \u201cA new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy,\u201d Endoscopy, vol. 38, no. 8, pp. 819\u2013824, 2006. <\/em><\/li><\/ol>

    Non-magnified NBI shows the non- metaplastic mucosa as brown and the intestinal metaplasia as areas with light blue crests (LBCs) <\/p>

    <\/div>

    Case A: <\/h2>